Our results showed that Bp7 and Bp8 intervention obviously reduced the colonic TNF-α and IL-1β levels and significantly elevated the colonic IL-10 levels, indicating that Bp7 or Bp8 effectively relieved the development of inflammation in colitis mice. This evidence concerns the gene IL1B and colitis.